Dong-Cho Han

Title: Innovations of Dong-Cho Han in Cancer Treatment

Introduction

Dong-Cho Han is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of cancer research through his innovative inventions. With a total of 2 patents, his work focuses on developing pharmaceutical compositions that aim to prevent and treat various types of cancers.

Latest Patents

One of his latest patents is an anticancer composition comprising obovatol or obovatal. This composition exhibits the ability to inhibit the growth of cancer cells and suppress the expression and activity of matrix metalloproteinases (MMPs). It holds promise for the prophylaxis and treatment of cancer, as well as for inhibiting cancer metastasis. Another notable patent involves pharmaceutical compositions of diaryl-isoxazole derivatives for the prevention and treatment of cancers. These derivatives are effective in inhibiting metastasis of breast cancer cell lines and angiogenesis, making them valuable for treating various angiogenesis-related diseases.

Career Highlights

Dong-Cho Han is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His work at this esteemed institution has allowed him to focus on groundbreaking research in the field of bioscience and biotechnology, particularly in cancer treatment.

Collaborations

He has collaborated with notable coworkers, including Byoung-Mog Kwon and Kwang-Hee Son, to further advance his research and innovations in cancer therapies.

Conclusion

Dong-Cho Han's contributions to cancer research through his innovative patents highlight his commitment to improving treatment options for patients. His work continues to pave the way for advancements in the field of oncology.